Lucintel's latest market report analyzed that biopharmaceutical CMO & CRO provides attractive opportunities in the pharmaceutical, biotechnological, and medical device industries. The biopharmaceutical CMO & CRO market is expected to grow at a CAGR of 7%-9%. In this market, biologics are the largest segment by product, whereas mammalian are largest by source.
Download Brochure of this report by clicking on https://www.lucintel.com/biopharmaceutical-cmo-aand-cro-market.aspx
Based on product, the biopharmaceutical
CMO & CRO market is segmented into biologics (monoclonal antibodies (MAbs),
recombinant proteins, vaccines, antisense, RNAi, & molecular therapy, and
others) and biosimilars. The biologics segment accounted for the largest share
of the market in 2020 due to complex manufacturing steps, high specificity of
biologics, and a higher success rate than other drug molecules.
Browse in-depth TOC on “Biopharmaceutical
CMO & CRO Market”
XX – Tables
XX – Figures
150– Pages
The biopharmaceutical CMO
& CRO market is marked by the presence of several big and small players.
Some of the prominent players offering biopharmaceutical CMO & CRO include Lonza,
Rentschler Biotechnologie, Boehringer Ingelheim, JRS Pharma, Inno Biologics,
ProBioGen, Fujifilm Diosynth Biotechnologies, Samsung BioLogics, and Toyobo.
Request Sample Report:
https://www.lucintel.com/biopharmaceutical-cmo-aand-cro-market.aspx
This unique research report will enable you
to make confident business decisions in this globally competitive marketplace. For
a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on
this link helpdesk@lucintel.com.
About Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally
Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy
Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor
Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx
No comments:
Post a Comment